The present study investigated the antifibrotic effect of uMSC-EVs using a bleomycin (BLM)-induced mouse model, and our results demonstrated that uMSC-EVs alleviated PF through inhibiting the TGF-β signaling pathway. The gene discussed is TGFB1; the disease is pemphigus foliaceus.